Country’s leading service provider of research development Vivo Bio Tech on Thursday said the board of company has approved the preferential allotment of equity shares to other strategic investors.

“The Board of Directors of the company at its meeting held on August 29, 2013, sanctioned the preferential allotment of equity shares to other strategic investors,” Vivo Bio Tech said in a filing to Bombay Stock Exchange.

Besides, the board has also approved the notice and directors reports of 26th AGM.